Increased rates of invasive bacterial disease in late 2022.
Abscess
Group A Streptococcus
Invasive bacterial disease
Pandemic
Journal
European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
27
07
2023
accepted:
11
10
2023
revised:
29
09
2023
medline:
11
2
2024
pubmed:
26
10
2023
entrez:
26
10
2023
Statut:
ppublish
Résumé
Invasive bacterial disease is associated with significant morbidity and mortality. In winter 2022, there was an apparent increased rate of invasive bacterial disease compared to preceding years. Cross-site retrospective analysis of the three Children's Health Ireland (CHI) hospitals looking at children admitted between 1st October 2022-31st December 2022 (Q4) with community-acquired invasive bacterial disease, defined as an abscess in a normally sterile site in the head, neck and chest or isolation or PCR detection of Streptococcus pneumoniae, Neisseria meningitidis, Streptococcus pyogenes (Group A streptococcus) or Haemophilus influenzae from a normally sterile site. Case numbers were compared to Q4 in each of 2018-2021. Eighty-two children met the case definition in Q4 2022 vs 97 (Q4 2018-2021). In 2022, 42/82 (51%) were female, median age 3.75 years (1.5-8.25 years). Only 2 (2%) were immunosuppressed and 2 others (2%) had underlying neurodisability. Fifty (61%) were admitted on second or subsequent presentation to a healthcare setting. Fifty-six (68%) had an abscess in a sterile site. Bloodstream infection (positive blood culture or PCR: 24 (29%)) was the most common site of infection, followed by neck 22 (27%) and intracranial 12 (15%). Group A streptococcus (GAS) 27 (33%) was the most common organism isolated. Seven cases (9%) died in 2022 compared to 2 patients (2%) from 2018 to 2021 (p < 0.05). More children had Paediatric Overall Performance Category (POPC) scores > 1 in 2022 than 2018-2021 (p = 0.003). Conclusion: Invasive bacterial diseases increased in Q4 2022 with higher morbidity and mortality than in the preceding 4 years. Group A streptococcal infection was the most significant organism in 2022. What is known: • Invasive bacterial disease is the leading cause of childhood mortality globally. • There was an increase in cases of invasive Group A streptococcus infections reported in many countries (including Ireland) during the winter of 2022/23. What is new: • Head, neck and chest abscesses increased in Q4 of 2022 compared to the previous 4 years combined. • Invasive bacterial infections in Q4 of 2022 were associated with higher rates of mortality (9%), paediatric intensive care unit (PICU) admission (24%) and requirement for surgical drainage or intervention (67%) than in the preceding years.
Identifiants
pubmed: 37882822
doi: 10.1007/s00431-023-05282-9
pii: 10.1007/s00431-023-05282-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
323-334Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE et al (2015) Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385(9966):430–440
doi: 10.1016/S0140-6736(14)61698-6
pubmed: 25280870
Boeddha NP, Schlapbach LJ, Driessen GJ, Herberg JA, Rivero-Calle I, Cebey-López M et al (2018) Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS). Crit Care 22(1):1–13
doi: 10.1186/s13054-018-2052-7
Schlapbach LJ, Straney L, Alexander J, MacLaren G, Festa M, Schibler A et al (2015) Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002–13: a multicentre retrospective cohort study. Lancet Infect Dis 15(1):46–54
doi: 10.1016/S1473-3099(14)71003-5
pubmed: 25471555
Roland D, Gardiner A, Razzaq D, Rose K, Bressan S, Honeyford K et al (2023) Influence of epidemics and pandemics on paediatric ED use: a systematic review. Arch Dis Child 108(2):115–22
doi: 10.1136/archdischild-2022-324108
pubmed: 36162959
Dann L, Fitzsimons J, Gorman KM, Hourihane J, Okafor I (2020) Disappearing act: COVID-19 and paediatric emergency department attendances. Arch Dis Child 105(8):810–811
doi: 10.1136/archdischild-2020-319654
pubmed: 32518141
Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G (2020) Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health 4(5):e10–e11
doi: 10.1016/S2352-4642(20)30108-5
pubmed: 32278365
pmcid: 7146704
Lynn RM, Avis JL, Lenton S, Amin-Chowdhury Z, Ladhani SN (2021) Delayed access to care and late presentations in children during the COVID-19 pandemic: a snapshot survey of 4075 paediatricians in the UK and Ireland. Arch Dis Child 106(2):e8-e
Duncanson M, Wheeler BJ, Jelleyman T, Dalziel SR, McIntyre P (2021) Delayed access to care and late presentations in children during the COVID-19 pandemic New Zealand-wide lockdown: a New Zealand Paediatric Surveillance Unit study. J Paediatr Child Health 57(10):1600–1604
doi: 10.1111/jpc.15551
pubmed: 34003540
pmcid: 8242550
Brueggemann AB, van Rensburg MJJ, Shaw D, McCarthy ND, Jolley KA, Maiden MC et al (2021) Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health 3(6):e360–e370
doi: 10.1016/S2589-7500(21)00077-7
pubmed: 34045002
pmcid: 8166576
Amin-Chowdhury Z, Aiano F, Mensah A, Sheppard CL, Litt D, Fry NK et al (2021) Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study. England Clin Infect Dis 72(5):e65–e75
doi: 10.1093/cid/ciaa1728
pubmed: 33196783
Taha MK, Deghmane AE (2020) Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease. BMC Res Notes 13(1):399
doi: 10.1186/s13104-020-05241-9
pubmed: 32854773
pmcid: 7450896
Yeoh DK, Foley DA, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT et al (2021) Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis 72(12):2199–2202
doi: 10.1093/cid/ciaa1475
pubmed: 32986804
Control CFD (2021) Prevention. Increased interseasonal respiratory syncytial virus (RSV) activity in parts of the southern United States. Atlanta, USA
Rybak A, Levy C, Jung C, Béchet S, Batard C, Hassid F et al (2021) Delayed bronchiolitis epidemic in french primary care setting driven by respiratory syncytial virus: preliminary data from the Oursyn study, March 2021. Pediatr Infect Dis J 40(12):e511–e514
doi: 10.1097/INF.0000000000003270
pubmed: 34260480
Holdstock V, Twynam-Perkins J, Bradnock T, Dickson EM, Harvey-Wood K, Kalima P et al (2023) National case series of group A streptococcus pleural empyema in children: clinical and microbiological features. Lancet Infect Dis
van Kempen EB, Bruijning-Verhagen PCJ, Borensztajn D, Vermont CL, Quaak MSW, Janson JA et al (2023) Increase in invasive group a streptococcal infections in children in the Netherlands, a survey among 7 hospitals in 2022. Pediatr Infect Dis J 42(4):e122–e124
doi: 10.1097/INF.0000000000003810
pubmed: 36728741
CHI (2021) Children’s Health Ireland - Annual Report 2021. www.childrenshealthireland.ie : CHI
Pollack MM, Holubkov R, Funai T, Clark A, Moler F, Shanley T et al (2014) Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales. JAMA Pediatr 168(7):671–676
doi: 10.1001/jamapediatrics.2013.5316
pubmed: 24862461
pmcid: 4589215
CSO (2023) Census 2022: Summary Results. www.cso.ie : Central Statistics Office. 30th May 2023
Jain N, Lansiaux E, Reinis A (2023) Group A streptococcal (GAS) infections amongst children in Europe: taming the rising tide. New Microbes New Infect 51:101071
doi: 10.1016/j.nmni.2022.101071
pubmed: 36593885
Cobo-Vázquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J (2023) Increasing incidence and severity of invasive Group A streptococcal disease in Spanish children in 2019–2022. Lancet Reg Health Eur 27:100597
doi: 10.1016/j.lanepe.2023.100597
pubmed: 36895202
pmcid: 9989682
Mordha EO (2023) National paediatric iGAS case review - request for contribution of data. In: Ireland NHPSo, editor
HPSC (2023) Latest update on the 2022–2023 upsurge in invasive Group A streptococcus (iGAS) infections in Ireland. www.hpsc.ie
Boeddha NP, Atkins L, de Groot R, Driessen G, Hazelzet J, Zenz W et al (2023) Group A streptococcal disease in paediatric inpatients: a European perspective. Eur J Pediatr 182(2):697–706
doi: 10.1007/s00431-022-04718-y
pubmed: 36449079
Hermon MM, Etmayr T, Brandt JB, Sadeghi K, Burda G, Golej J (2021) Pediatric infection and sepsis in five age subgroups: single-center registry. Wien Med Wochenschr 171(1–2):29–35
doi: 10.1007/s10354-020-00787-6
pubmed: 33108806
Baker AH, Monuteaux MC, Eisenberg MA, Hudgins JD (2022) Pediatric sepsis survival in pediatric and general emergency departments. Am J Emerg Med 51:53–57
doi: 10.1016/j.ajem.2021.10.007
pubmed: 34673476
HSE (2022) Immunisation uptake at 12 and 24 months of age in Ireland www.immunisation.ie . Health Protection Surveillance Centre
Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T et al (2005) Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 11(7):1062–1066
doi: 10.3201/eid1107.040900
pubmed: 16022781
pmcid: 3371775
Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A (2000) Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 105(5):E60
NIAC (2023) Recommendations regarding immunisation of children ages 2 months to 5 years. www.rcpi.ie . Royal College of Physicians of Ireland. National Immunisation Advisory Committee (NIAC). 15 Feb 2023
HIQA (2023) Report on the results of the public consultation on the Health Technology Assessment of the expansion of the childhood immunisation schedule to include varicella (chickenpox) vaccination. www.hiqa.ie : Health Information and Quality Authority. 13th July 2023
WHO (2023) WHO/UNICEF Joint Reporting Form on Immunization. www.immunizationdata.who.int : World Health Organisation
HPSC (2023) Seasonal influenza vaccine uptake in Ireland in 2022–2023 season, week 18 2023. www.hpsc.ie . 9th May 2023
Cohen R, Pettoello-Mantovani M, Somekh E, Levy C (2022) European pediatric societies call for an implementation of regular vaccination programs to contrast the immunity debt associated to coronavirus disease-2019 pandemic in children. J Pediatr 242:260–1.e3
doi: 10.1016/j.jpeds.2021.11.061
pubmed: 34848191
Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C et al (2021) Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now 51(5):418–423
doi: 10.1016/j.idnow.2021.05.004
pubmed: 33991720
pmcid: 8114587
Hurley S, Franklin R, McCallion N, Byrne AM, Fitzsimons J, Byrne S et al (2022) Allergy-related outcomes at 12 months in the CORAL birth cohort of Irish children born during the first COVID 19 lockdown. Pediatr Allergy Immunol 33(3):e13766
doi: 10.1111/pai.13766
pubmed: 35338733
pmcid: 9115474
Kadambari S, Goldacre R, Morris E, Goldacre MJ, Pollard AJ (2022) Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study. BMJ 376:e067519
doi: 10.1136/bmj-2021-067519
pubmed: 35022215
Hatter L, Eathorne A, Hills T, Bruce P, Beasley R (2021) Respiratory syncytial virus: paying the immunity debt with interest. Lancet Child Adolesc Health 5(12):e44–e45
doi: 10.1016/S2352-4642(21)00333-3
pubmed: 34695374
pmcid: 8598182
Bakaletz LO (2017) Viral–bacterial co-infections in the respiratory tract. Curr Opin Microbiol 35:30–35
doi: 10.1016/j.mib.2016.11.003
pubmed: 27940028
Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339(8):520–532
doi: 10.1056/NEJM199808203390806
pubmed: 9709046
Howden BP, Giulieri SG, Wong Fok Lung T, Baines SL, Sharkey LK, Lee JYH et al (2023) Staphylococcus aureus host interactions and adaptation. Nat Rev Microbiol 21(6):380–95
Othman AM, Assayaghi RM, Al-Shami HZ, Saif-Ali R (2019) Asymptomatic carriage of Streptococcus pyogenes among school children in Sana’a city, Yemen. BMC Res Notes 12(1):339
doi: 10.1186/s13104-019-4370-5
pubmed: 31200755
pmcid: 6570875
Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A et al (2014) Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev 27(2):264–301
doi: 10.1128/CMR.00101-13
pubmed: 24696436
pmcid: 3993104
Ramos La Cuey B, Saloni-Gomez N, Ilundain López de Munain A, Fernández-Montero A, Viguria N, López Fernández L et al (2023) The long-term boomerang effect of COVID-19 on admissions for non-COVID diseases: the ECIEN-2022 study. Eur J Pediatr
Kriz P, Bobak M, Kriz B (2000) Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study. Arch Dis Child 83(2):117–121
doi: 10.1136/adc.83.2.117
pubmed: 10906015
pmcid: 1718425
Curtis M, Kanis J, Wagers B, Coffee RL Jr, Sarmiento E, Grout S et al (2023) Immunization status and the management of febrile children in the pediatric emergency department: what are we doing? Pediatr Emerg Care 39(1):1–5
doi: 10.1097/PEC.0000000000002864
pubmed: 36279221